Tobi-D (Tobramycin with Dexamethasone) Eyes Drops
Description
Tobi-D (Tobramycin with Dexamethasone) Eye Drops is a prescription ophthalmic solution combining an antibiotic and a corticosteroid to treat specific bacterial eye infections accompanied by inflammation.
________________________________________
✅ Primary Uses
Tobi-D is primarily used for:
• Bacterial Conjunctivitis: Infection of the conjunctiva (the membrane covering the white part of the eye and the inner surface of the eyelids).
• Keratitis: Infection of the cornea.
• Post-surgical Infections: Prophylactic treatment or management of infections following eye surgeries.
It addresses both the infection and the inflammation associated with these conditions.
________________________________________
💊 Dosage and Administration
• Standard Dosage: Instill 1–2 drops into the affected eye(s) every 4–6 hours, or as directed by your healthcare provider.
• Application Tips:
o Wash your hands before use.
o Avoid touching the dropper tip to any surface, including the eye, to prevent contamination.
o If you wear contact lenses, remove them before applying the drops and wait at least 15 minutes before reinserting them.
________________________________________
⚠️ Contraindications and Cautions
• Contraindications:
o Hypersensitivity to tobramycin, dexamethasone, or any component of the formulation.
o Active viral infections of the eye, such as herpes simplex keratitis.
o Untreated fungal or mycobacterial infections of the eye.
• Cautions:
o Use with caution in patients with a history of glaucoma, as corticosteroids can increase intraocular pressure.
o Prolonged use may lead to cataract formation or secondary ocular infections.
o Consult your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding.
________________________________________
🧪 Mechanism of Action
• Tobramycin: An aminoglycoside antibiotic that inhibits bacterial protein synthesis, leading to bacterial cell death.
• Dexamethasone: A corticosteroid that reduces inflammation by inhibiting the release of inflammatory mediators.
Together, these components address both the infection and the inflammation associated with certain eye conditions.
